These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22170275)

  • 41. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging.
    Solfrizzi V; Scafato E; Capurso C; D'Introno A; Colacicco AM; Frisardi V; Vendemiale G; Baldereschi M; Crepaldi G; Di Carlo A; Galluzzo L; Gandin C; Inzitari D; Maggi S; Capurso A; Panza F;
    Neurobiol Aging; 2011 Nov; 32(11):1932-41. PubMed ID: 20045217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dementia in Parkinson's disease].
    Caixeta L; Vieira RT
    Braz J Psychiatry; 2008 Dec; 30(4):375-83. PubMed ID: 19142415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mild cognitive impairment and Parkinson's disease--something to remember.
    Barker RA; Williams-Gray CH
    J Parkinsons Dis; 2014; 4(4):651-6. PubMed ID: 25147139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI and cognitive impairment in Parkinson's disease.
    Ibarretxe-Bilbao N; Tolosa E; Junque C; Marti MJ
    Mov Disord; 2009; 24 Suppl 2():S748-53. PubMed ID: 19877242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease.
    Nagano-Saito A; Habak C; Mejía-Constaín B; Degroot C; Monetta L; Jubault T; Bedetti C; Lafontaine AL; Chouinard S; Soland V; Ptito A; Strafella AP; Monchi O
    Neurobiol Aging; 2014 Jan; 35(1):223-31. PubMed ID: 23932879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The assessment of cognitive impairment suspected of dementia in Polish elderly people: results of the population-based PolSenior Study.
    Klich-Rączka A; Piotrowicz K; Mossakowska M; Skalska A; Wizner B; Broczek K; Wieczorowska-Tobis K; Grodzicki T
    Exp Gerontol; 2014 Sep; 57():233-42. PubMed ID: 24937034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can mild cognitive impairment be accurately diagnosed in english speakers from linguistic minorities? Results from the Sydney Memory and Ageing study.
    Low LF; Harrison F; Kochan NA; Draper B; Slavin MJ; Reppermund S; Sachdev PS; Brodaty H
    Am J Geriatr Psychiatry; 2012 Oct; 20(10):866-77. PubMed ID: 22261551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mild cognitive impairment in clinical practice].
    Olazarán Rodríguez J; Bermejo Pareja F
    Med Clin (Barc); 2011 Oct; 137(9):414-8. PubMed ID: 21163505
    [No Abstract]   [Full Text] [Related]  

  • 52. Evolution of mild cognitive impairment in Parkinson disease.
    Picillo M; Barone P; Pellecchia MT; Santangelo G; Kano O; Ikeda K; Iwasaki Y
    Neurology; 2014 Apr; 82(15):1384. PubMed ID: 24733858
    [No Abstract]   [Full Text] [Related]  

  • 53. Postmenopausal estrogen use and Parkinson's disease with and without dementia.
    Marder K; Tang MX; Alfaro B; Mejia H; Cote L; Jacobs D; Stern Y; Sano M; Mayeux R
    Neurology; 1998 Apr; 50(4):1141-3. PubMed ID: 9566410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of dementia after fluctuating mild cognitive impairment: when the yo-yoing stops.
    Zonderman AB; Dore GA
    Neurology; 2014 Jan; 82(4):290-1. PubMed ID: 24353338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expert opinion on managing chronic HCV in patients with neuropsychiatric manifestations.
    Forton D; Weissenborn K; Bondin M; Cacoub P
    Antivir Ther; 2018; 23(Suppl 2):47-55. PubMed ID: 30451150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of Parkinson's disease in Izumo City, Japan.
    Okada K; Kobayashi S; Tsunematsu T
    Gerontology; 1990; 36(5-6):340-4. PubMed ID: 2076832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of Parkinson's disease.
    Elbaz A; Carcaillon L; Kab S; Moisan F
    Rev Neurol (Paris); 2016 Jan; 172(1):14-26. PubMed ID: 26718594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The treatment of mild cognitive impairment associated with Parkinson's disease.
    Burn DJ
    Mov Disord; 2015 Jun; 30(7):881-2. PubMed ID: 26011710
    [No Abstract]   [Full Text] [Related]  

  • 59. Cholinesterase inhibitors should not be prescribed for mild cognitive impairment.
    Russ TC
    Evid Based Med; 2014 Jun; 19(3):101. PubMed ID: 24482151
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection and Prevention of Cognitive Decline.
    Small GW
    Am J Geriatr Psychiatry; 2016 Dec; 24(12):1142-1150. PubMed ID: 27745823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.